Issued on 7 January, the Department of Health circular offers guidance to clinicians regarding the use of two-in-one combination antiretrovirals (ARV) following a change in ARV tendering.
After months of erratic supply of its antiretroviral (ARV) Aluvia in South Africa, international pharmaceutical company AbbVie will now allow generic manufacturers to produce the drug to help safeguard supplies, according to an announcement made today.
The latest UNAIDS report notes 15.8 million people were on antiretrovirals as of June and encourages more countries to heed the World Health’s Organisation’s call to roll out the “test and treat” approach.
In an effort to combat medicine shortages, South Africa will roll out a first of its kind early warning system to identify drug stock outs before they happen. The move comes as country and makers of the antiretroviral Aluvia work to address shortages
In a landmark move, the World Health Organisation (WHO) has recommended that all people living with HIV be started on treatment as soon as possible following diagnosis.